[Diagnosis of olfactory disorders--clinical standards and research].
Olfactory dysfunction has been reported to affect about 79,000 patients who were treated annually in German ORL-hospitals. The incidence of olfactory dysfunctions emphasizes the need for diagnostic strategies. This article features on the dysfunction of human olfaction including neurodegenerative diseases. Standard procedures for the psychophysical and objective assessment of olfactory function are presented. Current diagnostic imaging techniques for routine use and scientific approaches are discussed.
Klinik und Poliklinik für Hals-Nasen- und Ohrenheilkunde am Klinikum der Universität zu Köln. michael.damm@uni-koeln.de
M
M
Damm
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000679:Amygdala / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D002628:Chemoreceptor Cells / Q000187:drug effects / Q000503:physiopathology; D004569:Electroencephalography / Q000295:instrumentation; D004867:Equipment Design; D005071:Evoked Potentials / Q000187:drug effects / Q000502:physiology; D006179:Gyrus Cinguli / Q000187:drug effects / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D019636:Neurodegenerative Diseases / Q000175:diagnosis / Q000503:physiopathology; D000857:Olfaction Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D020431:Olfactory Nerve Diseases / Q000175:diagnosis / Q000503:physiopathology; D009833:Olfactory Pathways / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D010036:Otolaryngology / Q000295:instrumentation; D012684:Sensory Thresholds / Q000187:drug effects / Q000502:physiology; D012903:Smell; D014057:Tomography, X-Ray Computed; D014276:Trigeminal Nerve / Q000187:drug effects / Q000503:physiopathology
D000305:Adrenal Cortex Hormones